Translate Bio, Sanofi COVID-19 vaccine candidate produces immune response in animal studies
Aug 25 (Reuters) - Translate Bio Inc TBIO.O said on Tuesday that an experimental coronavirus vaccine it developed with French drugmaker Sanofi SA SASY.PA induced immune response in early-stage non-human primate studies.
In a regulatory filing, the company cited Sanofi's presentation slides showing that the vaccine candidate induced neutralizing antibodies and T-cell responses in animal studies.
(Reporting by Manojna Maddipatla in Bengaluru; Editing by Maju Samuel)
((email@example.com; +91 8061822700;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Latest Markets Videos
- Fed could cut rates in 2023, 2024 once inflation under control -Bullard
- US STOCKS-Wall St plunges as Snap's bleak forecast sparks selloff
- All Fed officials backed May rate hike, 'most' saw half-point rises in June and July, minutes show
- US STOCKS-Wall Street surges on upbeat retail guidance, easing Fed fears